Q1 Earnings Forecast for Prime Medicine Issued By Wedbush
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Research analysts at Wedbush issued their Q1 2026 earnings per share estimates for Prime Medicine in a research report issued on Thursday, May 8th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.38) per share for the quarter. Wedbush currently has a “Outperform” […]
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Research analysts at Wedbush issued their Q1 2026 earnings per share estimates for Prime Medicine in a research report issued on Thursday, May 8th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.38) per share for the quarter. Wedbush currently has a “Outperform” […]
